Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

Nov 3, 2009 9 related

Ironwood Pharmaceuticals, Inc. and Forest Laboratories, Inc. (NYSE: FRX) today announced positive top-line results from two Phase 3 clinical trials assessing the safety and efficacy of once-daily dosing of the investigational... [read full story]

Add Comment

There are also 9 related articles

View all news articles about*:

*Newstin tag cloud displays all featured persons, associated organizations, related topics, regions and companies

Send to a friend | Bookmark with

NewstinMap

Click to Open NewstinMap —

Visual Navigation

My Newstin

Context

Senior Management
Scientific Discoveries
General Management Issues
Health Care
Gastrointestinal Symptoms
Abdominal Pain
Pain
Patients
Pharmaceuticals
Ambulatory Health Care
Diarrhea
Scientific Conferences
Bloating
CEO
Constipation
Medical Research

Forest Laboratories

Intelligent Data Fusion

About Us

Visit our corporate homepage to learn more about our company and products.

Ironwood and Forest Announce Positive Linaclotide Results from Two Pivotal Phase 3 Trials in...

View other selected articles:

Health Robotics Forms a Canadian Joint Venture with Investors

Officials: CityCenter not affected by debt problems

FullArmor PolicyPortal for Windows Azure: Enterprise Policy Management Podcast with Danny Kim ?...

If shopping in Northern Ireland saves you enough for a doctor's visit, then what's the problem?...

International Editions